자동 로그아웃 안내

로그아웃 아이콘

로그아웃 시간이 남았습니다.
로그인 시간을 연장하시겠습니까?

로그아웃을 연장하시려면 아래 연장하기 버튼을 눌러주세요.

본문 바로가기

연구소

연구논문

  • Home
  • 연구소
  • 연구논문

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy 정진수
(이행성연구부)
정진수:김성한:Boram Park, Eu Chang Hwang, Sung-Hoo Hong, Chang Wook Jeong, Cheol Kwak, Seok Soo Byun,. Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy SCIENTIFIC REPORTS. 2021-02-04; 2021; 11(1):3079~. IF 4.38 (2020)
김성한
(종양면역학연구부)
Dietary patterns and gastric cancer risk in a Korean population: a case-control study 김정선
(암의생명과학과)
김정선:김지현:이정희, 최일주, 김영일. Dietary patterns and gastric cancer risk in a Korean population: a case-control study EUROPEAN JOURNAL OF NUTRITION. 2021-02-01; 2020; 60(1):389~397. IF 4.664 (2019)
김지현
(암관리학과)
Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation 이은영
(혈액종양내과분과)
이은영:정종헌:이혜원1, 서양권, 엄현석. Current Use of Total Body Irradiation in Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation JOURNAL OF KOREAN MEDICAL SCIENCE. 2021-02-01; 2021; 36(8):e55~. IF 2.153 (2020)
정종헌
(혈액종양내과분과)
Potentiating the Antitumor Activity of Cytotoxic T Cells via the Transmembrane Domain of IGSF4 That Increases TCR Avidity Chang-Duk Jun
Chang-Duk Jun:김혜란, Jeong-Su Park:. Potentiating the Antitumor Activity of Cytotoxic T Cells via the Transmembrane Domain of IGSF4 That Increases TCR Avidity FRONTIERS IN IMMUNOLOGY. 2021-02-01; 2021; 11:591054~. IF 7.561 (2020)
김혜란
(종양면역연구과)
Feasibility of implementing a national lung cancer screening
program: Interim results from the Korean Lung Cancer Screening
Project (K-LUCAS) 김열
(가정의학과)
김열:Jaeho Lee:김혜영, 임준태, 이찬화, 최귀선, 박보영, 이덕형. Feasibility of implementing a national lung cancer screening program: Interim results from the Korean Lung Cancer Screening Project (K-LUCAS) TRANSLATIONAL LUNG CANCER RESEARCH. 2021-02-01; 2021; 10(2):723~736. IF 6.498 (2020)
Jaeho Lee
Preclinical evaluation of radiation therapy of BRCA1-associated mammary tumors using a mouse model 김상수
(융합기술연구부)
김상수:조은주:김종광, 백혜정, 박은정, 최범규, 김태현, 신동훈, 임영경. Preclinical evaluation of radiation therapy of BRCA1-associated mammary tumors using a mouse model INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES. 2021-01-31; 2021; 17(3):689~701. IF 6.582 (2020)
조은주
(융합기술연구부)
Risk factors of undiagnosed diabetes mellitus among Korean adults: a national cross-sectional study using the KNHANES data 차효성
(암빅데이터센터)
차효성:이상원, 류광선:강하예진, 유나영, 최귀선, 황보율, 이재욱. Risk factors of undiagnosed diabetes mellitus among Korean adults: a national cross-sectional study using the KNHANES data INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2021-01-29; 2021; 18(3):1195~. IF 3.39 (2020)
이상원
(암빅데이터센터)
류광선
(암등록감시부)
High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma 엄현석
(혈액종양내과분과)
엄현석:정종헌, 이혜원1:이은영, 박원서. High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma SCIENTIFIC REPORTS. 2021-01-29; 2021; 11(1):2674~. IF 4.38 (2020)
정종헌
(혈액종양내과분과)
이혜원1
(종양면역학연구부)
The Clinical Impact of Capmatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification 한지연1
(폐암센터)
한지연:최원영:박석연, 이영주, 임근영, 박민정, 이건국. The Clinical Impact of Capmatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification CANCER RESEARCH AND TREATMENT. 2021-01-29; 2021; Online:Published. IF 4.679 (2020)
최원영
(임상시험센터)
Risk of coronary heart disease among cancer survivors with different prediagnosis body mass index Minseon Park
Minseon Park:김규웅, Ahryoung Ko:. Risk of coronary heart disease among cancer survivors with different prediagnosis body mass index SCIENTIFIC REPORTS. 2021-01-28; 2021; 11(1):2453~. IF 4.38 (2020)
김규웅
(암관리정책부)